NEW YORK (GenomeWeb News) - Clinical Data today reported a 39 percent increase in revenues for its fiscal first quarter, driven by double-digit revenue growth in its PGxHealth and Cogenics divisions.
 
Clinical Data's total revenue for the quarter ended June 30, 2008, soared 39 percent to $9.2 million from $6.6 million for the same period a year ago.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.